Zealand Pharma presents positive clinical and health economic outcome data with use of regular human insulin delivered by the V-Go in adults with type 2 diabetes
Zealand Pharma A/S - American Depositary Shares (ZEAL)
Last zealand pharma a/s - american depositary shares earnings: 11/15 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
zealandpharma.com
Company Research
Source: GlobeNewswire
Company announcement – No. 20 / 2020 Zealand Pharma presents positive clinical and health economic outcome data with use of regular human insulin delivered by the V-Go in adults with type 2 diabetes Results of this 14-week randomized multi-center trial demonstrate non-inferiority for change in overall blood sugar levels (HbA1c) between U-100 regular human insulin and U-100 rapid acting insulin analogs when delivered by V-Go® The 30-day insulin cost per patient was calculated to be $265.16 for the regular human insulin group and $533.70 for the rapid acting insulin group at the end of trial V-Go® is a patient fillable insulin delivery device cleared by the FDA for the administration of insulin for the management of diabetes mellitus in adults requiring insulin The use of U-100 Regular Human Insulin with V-Go® Wearable Insulin Delivery device has not yet been cleared by the Food and Drug Administration or European Union Copenhagen, April 15, 2020 – Zealand Pharma A/S (“Zealand”) (NA
Show less
Read more
Impact Snapshot
Event Time:
ZEAL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZEAL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZEAL alerts
High impacting Zealand Pharma A/S - American Depositary Shares news events
Weekly update
A roundup of the hottest topics